MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Cheston Larson
Cheston LarsonLatham & Watkins

Cheston Larson

Partner at Latham & Watkins

Lawyer

San Diego

Deal Bio

Total Deals36
Valued Deals27
Total Value£ 20.17 B
Avg. Deal Size£ 747 M

Market Context

Sort

10 Mar 2015|United States|Pharmaceuticals
Zohydro Er Business Of Zogenix Inc.
Pernix Therapeutics Holdings Inc.

Target: ZOHYDRO ER BUSINESS OF ZOGENIX INC.

Bidder: PERNIX THERAPEUTICS HOLDINGS INC.

1 Service Providers

1 Vendor

2 Dealmakers

2 Vendor

£ 66 M

Value

05 May 2015|United States|Health Care Services
Zavante Therapeutics Inc.
Sg Pharmaceuticals Inc.

Target: ZAVANTE THERAPEUTICS INC.

Bidder: SG PHARMACEUTICALS INC.

1 Service Providers

1 Bidder

1 Dealmakers

1 Bidder

n/a

Value

22 Dec 2017|United States|Biotechnology
Ignyta
Roche Holdings

Target: IGNYTA INC

Bidder: ROCHE HOLDINGS AG

5 Service Providers

3 Target | 2 Bidder

5 Dealmakers

5 Target

n/a

Value

16 Nov 2015|United States|Distillers and Vintners
Home Brew Mart
Constellation Brands

Target: HOME BREW MART INC

Bidder: CONSTELLATION BRANDS

1 Service Providers

1 Target

3 Dealmakers

3 Target

n/a

Value

05 Jan 2016|United States|Medical Equipment
Ellipse Technologies
Nuvasive

Target: ELLIPSE TECHNOLOGIES INC

Bidder: NUVASIVE INC

1 Service Providers

1 Target

2 Dealmakers

2 Target

n/a

Value

23 Jul 2018|United States|Health Care Services
Zavante Therapeutics Inc.
Nabriva Therapeutics

Target: ZAVANTE THERAPEUTICS INC.

Bidder: NABRIVA THERAPEUTICS PLC

4 Service Providers

2 Target | 2 Bidder

2 Dealmakers

2 Target

£ 93 M

Value

14 Sep 2018|United States|Biotechnology
Bonti
Allergan

Target: BONTI INC

Bidder: ALLERGAN PLC

1 Service Providers

1 Target

2 Dealmakers

2 Target

n/a

Value

03 Dec 2018|United States|Pharmaceuticals
Aegis Therapeutics
Neurelis

Target: AEGIS THERAPEUTICS

Bidder: NEURELIS INC

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

n/a

Value

20 Feb 2019|United States|Distillers and Vintners
Cutwater Spirits
Anheuser Busch Inbev

Target: CUTWATER SPIRITS

Bidder: ANHEUSER BUSCH INBEV

3 Service Providers

2 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

n/a

Value

07 Mar 2019|United States|Pharmaceuticals
Gtx
Oncternal Therapeutics

Target: GTX INC

Bidder: ONCTERNAL THERAPEUTICS

6 Service Providers

3 Target | 3 Bidder

3 Dealmakers

1 Target | 2 Bidder

n/a

Value

27 Apr 2020|United States|Biotechnology
ERASCA
Arch Venture Partners

Target: ERASCA

Bidder: ARCH VENTURE PARTNERS

10 Service Providers

3 Target | 7 Bidder

22 Dealmakers

8 Target | 14 Bidder

£ 161 M

Value

25 Aug 2020|United States|Biotechnology
Chart Industries (mve Biological Products)
Blackstone Group

Target: CHART INDUSTRIES INC (MVE BIOLOGICAL PRODUCTS)

Bidder: BLACKSTONE GROUP INC

10 Service Providers

7 Bidder | 3 Vendor

48 Dealmakers

35 Bidder | 13 Vendor

£ 244 M

Value

21 Sep 2020|United States|Medical Services
GRAIL
Illumina

Target: GRAIL

Bidder: ILLUMINA INC

29 Service Providers

7 Target | 7 Bidder | 15 Vendor

107 Dealmakers

42 Target | 41 Bidder | 24 Vendor

£ 6.19 B

Value

30 Dec 2020|United States|Biotechnology
Mineralys Therapeutics
Hbm Healthcare Investments

Target: MINERALYS THERAPEUTICS INC

Bidder: HBM HEALTHCARE INVESTMENTS

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 25 M

Value

19 Mar 2021|United States|Medical Services
Icosavax
Sanofi Ventures

Target: ICOSAVAX INC

Bidder: SANOFI VENTURES

13 Service Providers

2 Target | 11 Bidder

19 Dealmakers

7 Target | 12 Bidder

£ 71 M

Value

28 Apr 2021|United States|Biotechnology
Boundless Bio
Wellington Management

Target: BOUNDLESS BIO

Bidder: WELLINGTON MANAGEMENT

15 Service Providers

3 Target | 12 Bidder

16 Dealmakers

4 Target | 12 Bidder

£ 75 M

Value

17 May 2021|Singapore|Biotechnology
Hummingbird Bioscience
Frazier Healthcare Partners

Target: HUMMINGBIRD BIOSCIENCE

Bidder: FRAZIER HEALTHCARE PARTNERS

18 Service Providers

1 Target | 17 Bidder

18 Dealmakers

1 Target | 18 Bidder

£ 88 M

Value

27 May 2021|United States|Biotechnology
Effector Therapeutics
Locust Walk Acquisition Corp

Target: EFFECTOR THERAPEUTICS

Bidder: LOCUST WALK ACQUISITION CORP

21 Service Providers

7 Target | 14 Bidder

33 Dealmakers

23 Target | 10 Bidder

£ 296 M

Value

26 May 2021|United States|Biotechnology
Nikang Therapeutics
Surveyor Capital

Target: NIKANG THERAPEUTICS

Bidder: SURVEYOR CAPITAL

23 Service Providers

2 Target | 21 Bidder

29 Dealmakers

5 Target | 24 Bidder

£ 141 M

Value

29 Nov 2021|United States|Cosmetics
Alastin Skincare
GALDERMA

Target: ALASTIN SKINCARE

Bidder: GALDERMA

5 Service Providers

3 Target | 2 Bidder

41 Dealmakers

23 Target | 18 Bidder

n/a

Value

21 Oct 2021|United States|Medical Equipment
Zerigo Health
Leaps By Bayer

Target: ZERIGO HEALTH

Bidder: LEAPS BY BAYER

8 Service Providers

2 Target | 6 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 31 M

Value

19 Jan 2022|United States|Pharmaceuticals
Zogenix
Ucb Pharma

Target: ZOGENIX INC

Bidder: UCB PHARMA SA

10 Service Providers

6 Target | 4 Bidder

56 Dealmakers

27 Target | 29 Bidder

£ 1.40 B

Value

15 Nov 2022|United States|Health Care Services
Cg Oncology
Ally Bridge Group

Target: CG ONCOLOGY

Bidder: ALLY BRIDGE GROUP

11 Service Providers

3 Target | 8 Bidder

12 Dealmakers

4 Target | 8 Bidder

£ 101 M

Value

21 Mar 2023|United States|Distillers and Vintners
SKREWBALL
Pernod Ricard

Target: SKREWBALL

Bidder: PERNOD RICARD SA

7 Service Providers

4 Target | 3 Bidder

47 Dealmakers

17 Target | 30 Bidder

£ 400 M

Value

16 Apr 2023|United States|Biotechnology
Prometheus Biosciences
Merck & Co

Target: PROMETHEUS BIOSCIENCES INC

Bidder: MERCK & CO

8 Service Providers

5 Target | 3 Bidder

50 Dealmakers

31 Target | 19 Bidder

£ 8.70 B

Value

16 May 2023|United States|Biotechnology
Boundless Bio
Leaps By Bayer

Target: BOUNDLESS BIO

Bidder: LEAPS BY BAYER

15 Service Providers

2 Target | 13 Bidder

16 Dealmakers

3 Target | 13 Bidder

£ 80 M

Value

12 Dec 2023|United States|Medical Services
Icosavax
Astrazeneca

Target: ICOSAVAX INC

Bidder: ASTRAZENECA PLC

7 Service Providers

5 Target | 2 Bidder

27 Dealmakers

6 Target | 21 Bidder

£ 876 M

Value

02 Aug 2023|United States|Health Care Services
Cg Oncology
Avidity Partners

Target: CG ONCOLOGY

Bidder: AVIDITY PARTNERS

5 Service Providers

3 Target | 2 Bidder

7 Dealmakers

5 Target | 2 Bidder

£ 82 M

Value

26 Feb 2024|Ireland|Medical Equipment
Mainstay Medical Holdings
Gilde Healthcare

Target: MAINSTAY MEDICAL HOLDINGS PLC

Bidder: GILDE HEALTHCARE

6 Service Providers

5 Target | 1 Bidder

8 Dealmakers

7 Target | 1 Bidder

£ 98 M

Value

21 Mar 2024|United States|Pharmaceuticals
Mirador Therapeutics
Orbimed Advisors

Target: MIRADOR THERAPEUTICS

Bidder: ORBIMED ADVISORS LLC

4 Service Providers

3 Target | 1 Bidder

7 Dealmakers

6 Target | 1 Bidder

£ 314 M

Value

03 Mar 2025|United States|Biotechnology
Callio Therapeutics
Omega Funds

Target: CALLIO THERAPEUTICS

Bidder: OMEGA FUNDS

13 Service Providers

2 Target | 11 Bidder

34 Dealmakers

17 Target | 17 Bidder

£ 148 M

Value

09 Jan 2025|United States|Biotechnology
Timberlyne Therapeutics
Venrock Healthcare Capital Partners

Target: TIMBERLYNE THERAPEUTICS

Bidder: VENROCK HEALTHCARE CAPITAL PARTNERS

2 Service Providers

2 Target

10 Dealmakers

10 Target

£ 145 M

Value

24 Jan 2024|United States|Renewable Energy Equipment
Sion Power Corporation
Euclidean Capital

Target: SION POWER CORPORATION

Bidder: EUCLIDEAN CAPITAL

3 Service Providers

2 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 59 M

Value

19 Feb 2025|United States|Software
SANAS
Teleperformance

Target: SANAS

Bidder: TELEPERFORMANCE SE

7 Service Providers

3 Target | 4 Bidder

11 Dealmakers

8 Target | 3 Bidder

£ 51 M

Value

31 Mar 2025|United States|Medical Services
Baylor Genetics
Decheng Capital

Target: BAYLOR GENETICS

Bidder: DECHENG CAPITAL LLC

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 78 M

Value

30 Sep 2025|United States|Pharmaceuticals
Crystalys Therapeutics
Longwood Fund

Target: CRYSTALYS THERAPEUTICS

Bidder: LONGWOOD FUND

2 Service Providers

2 Target

4 Dealmakers

4 Target

£ 152 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Cheston Larson